HomeCompareIMPX vs JNJ

IMPX vs JNJ: Dividend Comparison 2026

IMPX yields 21.30% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IMPX wins by $59.0K in total portfolio value
10 years
IMPX
IMPX
● Live price
21.30%
Share price
$9.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$79.1K
Annual income
$7,723.25
Full IMPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — IMPX vs JNJ

📍 IMPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMPX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IMPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMPX
Annual income on $10K today (after 15% tax)
$1,810.44/yr
After 10yr DRIP, annual income (after tax)
$6,564.76/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, IMPX beats the other by $5,861.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMPX + JNJ for your $10,000?

IMPX: 50%JNJ: 50%
100% JNJ50/50100% IMPX
Portfolio after 10yr
$49.5K
Annual income
$4,275.52/yr
Blended yield
8.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IMPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMPX buys
0
JNJ buys
0
No recent congressional trades found for IMPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMPXJNJ
Forward yield21.30%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$79.1K$20.0K
Annual income after 10y$7,723.25$827.78
Total dividends collected$46.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IMPX vs JNJ ($10,000, DRIP)

YearIMPX PortfolioIMPX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,830$2,129.93$10,676$355.77+$2.2KIMPX
2$16,282$2,553.91$11,407$389.39+$4.9KIMPX
3$20,451$3,029.02$12,198$426.53+$8.3KIMPX
4$25,438$3,555.67$13,056$467.62+$12.4KIMPX
5$31,352$4,133.43$13,987$513.12+$17.4KIMPX
6$38,308$4,761.13$14,998$563.56+$23.3KIMPX
7$46,426$5,436.86$16,098$619.52+$30.3KIMPX
8$55,834$6,158.01$17,295$681.69+$38.5KIMPX
9$66,664$6,921.38$18,599$750.82+$48.1KIMPX
10$79,053$7,723.25$20,022$827.78+$59.0KIMPX

IMPX vs JNJ: Complete Analysis 2026

IMPXStock

AEA-Bridges Impact Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on value-added industrials, including sustainable energy and energy efficiency, education, circular economy, consumer, healthcare, and business services. AEA-Bridges Impact Corp. was incorporated in 2020 and is based in Grand Cayman, Cayman Islands.

Full IMPX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this IMPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMPX vs SCHDIMPX vs JEPIIMPX vs OIMPX vs KOIMPX vs MAINIMPX vs ABBVIMPX vs MRKIMPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.